Engineering transcriptional regulation for cell-based therapies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Engineering transcriptional regulation for cell-based therapies

Published:2024-04 Issue:2 Volume:29 Page:100121
ISSN:2472-6303
Container-title:SLAS Technology
language:en
Short-container-title:SLAS Technology

Author:

Recktenwald Matthias^ORCID,Hutt Evan,Davis Leah^ORCID,MacAulay James^ORCID,Daringer Nichole M.^ORCID,Galie Peter A.^ORCID,Staehle Mary M.^ORCID,Vega Sebastián L.^ORCID

Funder

National Science Foundation

Publisher

Elsevier BV

Reference159 articles.

1. Synthetic biology in cell-based cancer immunotherapy;Chakravarti;Trends Biotechnol,2015

2. Engineering the next generation of cell-based therapeutics;Bashor;Nat Rev Drug Discov,2022

3. The evolution of synthetic receptor systems;Manhas;Nat Chem Biol,2022

4. Synthetic transcription factor engineering for cell and gene therapy;Bhatt;Trends Biotechnol,2023

5. Engineering strategies to overcome the current roadblocks in CAR T cell therapy;Rafiq;Nat Rev Clin Oncol,2020

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthetic Gene Circuits as a Promising Approach in Cancer Immunotherapy;Advances in Medical Diagnosis, Treatment, and Care;2024-08-28

2. Targeted Gene Therapy: Promises and Challenges in Disease Management;Journal of Bio-X Research;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP